Skip to main content
SpringerLink
Log in

Clinical trials for early (pre-dementia) Alzheimer’s disease: A case for mild cognitive impairment

  • Published:
The journal of nutrition, health & aging

Abstract

A goal of many clinical trials for Alzheimer℉s disease is to develop disease-modifying therapies for the pre-dementia period of the Alzheimer℉s disease process. However, there are no clinical criteria for characterizing subjects in this range. The construct of amnestic mild cognitive impairment has been extensively investigated and may provide useful clinical criteria for this clinical stage. It is proposed that the clinical criteria for mild cognitive impairment be enriched with imaging and other biomarkers to improve the specificity of the outcome, and these criteria might suffice for pre-dementia clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.

    Article  CAS  PubMed  Google Scholar 

  2. Petersen R, Knopman D, Boeve B, Geda Y, Ivnik R, Smith G, et al. Mild Cognitive Impairment: Ten Years Later. Neurology 2009; (in press).

  3. Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004;256:183–194.

    Article  CAS  PubMed  Google Scholar 

  4. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009;66:1151–1157.

    Article  PubMed  Google Scholar 

  5. Palmer K, Wang HX, Backman L, Winglad B, Fratiglioni L. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry 2002;159:436–442.

    Article  PubMed  Google Scholar 

  6. Dubois B, Feldman H, Jacova c, DeKosky S, Barberger-Gateau P, Cummings J, et al. Research Criteria for the Diagnosis of Alzheimer’s Disease: Revising the NINCDSADRDA Criteria. Lancet Neurol 2007;6:734–746.

    Article  PubMed  Google Scholar 

  7. Petersen R, Knopman D, Boeve B, Geda Y, Char R, Roberts R, et al. Predicting Alzheimer’s Disease. Alzheimer Dement 2009;5(suppl 1):130.

    Article  Google Scholar 

  8. Hunderfund AL, Roberts RO, Slusser TC, Leibson CL, Geda YE, Ivnik RJ, et al. Mortality in amnestic mild cognitive impairment: a prospective community study. Neurology 2006;67:1764–1768.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    R. C. Petersen

Authors
  1. R. C. Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. C. Petersen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petersen, R.C. Clinical trials for early (pre-dementia) Alzheimer’s disease: A case for mild cognitive impairment. J Nutr Health Aging 14, 304–305 (2010). https://doi.org/10.1007/s12603-010-0068-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-010-0068-z

Keywords

Search

Navigation